The TLR7 agonist imiquimod selectively inhibits IL-4-induced IgE production by suppressing IgG1/IgE class switching and germline ε transcription through the induction of BCL6 expression in B cells. [electronic resource]
- Cellular immunology 04 2019
- 1-8 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't